Amylon Therapeutics B.V.
Industry
- Biotechnology
- Gene Therapy, Cell Therapy
- Pharmaceuticals
Other Names/Subsidiaries
- ProQR
Latest on Amylon Therapeutics B.V.
Rising Leaders Home There is no age restriction to being included in the Rising Leaders list; the 30 people below were recognized for bringing something new to the game. The list focuses on achieveme
In this first edition of In Vivo's ‘Rising Leaders’ list, the focus is on entrepreneurs and innovators who represent the next wave of creativity in health care. Included are academics, CEOs of small
Financings Third-quarter 2017 biopharma financing reached $12.5 billion, just a 6% decrease from the previous quarter's $13.4 billion. ( See Exhibit 1. ) The most money was raised in the follow-on pub
Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biophar